[1]
Rouanet, J., Joulie, I., Lambert, C. and D’Incan, M. 2022. Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses. Acta Dermato-Venereologica. 102, (Jul. 2022), adv00746. DOI:https://doi.org/10.2340/actadv.v102.718.